<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17402" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Alpha-Fetoprotein Analysis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Adigun</surname>
            <given-names>Oluwaseun O.</given-names>
          </name>
          <aff>Medway NHS Trust</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yarrarapu</surname>
            <given-names>Siva Naga S.</given-names>
          </name>
          <aff>Monmouth Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zubair</surname>
            <given-names>Muhammad</given-names>
          </name>
          <aff>Indus Hospital &#x00026; Health Network</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khetarpal</surname>
            <given-names>Shailesh</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Oluwaseun Adigun declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Siva Naga Yarrarapu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Zubair declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shailesh Khetarpal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17402.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Human &#x003b1;-fetoprotein (AFP) is a tumor-associated fetal mammalian glycoprotein involved in ontogenic and oncogenic growth.<xref ref-type="bibr" rid="article-17402.r1">[1]</xref>&#x000a0;This tumor marker is encoded by the <italic toggle="yes">AFP</italic> gene on chromosome 4q25.<xref ref-type="bibr" rid="article-17402.r2">[2]</xref>&#x000a0;The fetal protein is a 70-kDa single polypeptide chain containing 3% to 5% carbohydrate. This protein exhibits&#x000a0;a triplicate domain structure configured by intramolecular loops dictated by disulfide bridging.<xref ref-type="bibr" rid="article-17402.r3">[3]</xref>&#x000a0;AFP occupies an &#x003b1;-1 anodic position in the electrophoretic profile, running slightly slower&#x000a0;compared to&#x000a0;albumin.<xref ref-type="bibr" rid="article-17402.r4">[4]</xref>&#x000a0;AFP is synthesized in the yolk sac, fetal liver, and gastrointestinal tract during pregnancy but is re-expressed in multiple adult tumors of mixed mesodermal&#x000a0;or endodermal origin.<xref ref-type="bibr" rid="article-17402.r5">[5]</xref></p>
        <p>In the clinical laboratory, AFP has been employed both as a post-operational tumor marker and as a gestational age-dependent fetal defect marker, demonstrating utility in screening for neural tube defects and aneuploidies.<xref ref-type="bibr" rid="article-17402.r6">[6]</xref> When a fetus has neural tube defects, maternal serum AFP levels are elevated, whereas chromosomal disorders are associated with lower levels.<xref ref-type="bibr" rid="article-17402.r7">[7]</xref>&#x000a0;Yolk sac and liver-derived AFP have different carbohydrate content. The half-life of AFP is 4 to 5 days.&#x000a0;Similar to albumin, serum AFP binds and transports many ligands such as bilirubin, fatty acids, retinoids, steroids, heavy metals, dyes, flavonoids, phytoestrogens, dioxin, and various drugs.<xref ref-type="bibr" rid="article-17402.r8">[8]</xref>&#x000a0;</p>
        <p>AFP can be fractionated by affinity electrophoresis into&#x000a0;3 glycoforms: L1, L2, and L3, based on the reactivity with the lectin lens culinaris agglutinin.<xref ref-type="bibr" rid="article-17402.r9">[9]</xref>&#x000a0;AFP-L3 binds strongly to&#x000a0;lens culinaris agglutinin through&#x000a0;an additional &#x003b1;-1-6 fucose residue attached at the reducing terminus of N-acetylglucosamine, in contrast to the L1 isoform. The L1 isoform is typically associated with non-hepatocellular carcinoma inflammation of the liver disease.<xref ref-type="bibr" rid="article-17402.r10">[10]</xref> The L3 isoform is specific to malignant tumors, and&#x000a0;the&#x000a0;detected presence can identify patients who need increased monitoring for the development of hepatocellular carcinoma in high-risk populations such as chronic hepatitis B and C and liver cirrhosis.<xref ref-type="bibr" rid="article-17402.r11">[11]</xref></p>
      </sec>
      <sec id="article-17402.s2" sec-type="Specimen Collection">
        <title>Specimen Collection</title>
        <p>A blood sample is collected from the vein using aseptic techniques, and universal precautions are observed. Serum AFP levels are measured as part of a maternal triple or quadruple screening test or for other diagnostic purposes&#x000a0;in nonpregnant female&#x000a0;or male&#x000a0;patients.<xref ref-type="bibr" rid="article-17402.r12">[12]</xref> Urine samples collected in plain or universal bottles may also be assayed for AFP levels, although this may be significantly lower compared to serum levels.<xref ref-type="bibr" rid="article-17402.r13">[13]</xref></p>
        <p>Specimens derived from sera are stable at room temperature or 4 &#x000b0;C for at least&#x000a0;1 week and can be stored for several months at &#x02212;20 &#x000b0;C. The type of centrifugation and non-stable refrigeration frost-free cycles can affect AFP levels.<xref ref-type="bibr" rid="article-17402.r14">[14]</xref> Thus, monitoring various steps involved in sample collecting, storage, and preparation processes is crucial in maternal serum AFP screening programs.<xref ref-type="bibr" rid="article-17402.r15">[15]</xref></p>
        <p>Amniocentesis is needed to&#x000a0;assay AFP levels in the amniotic fluid. A diagnostic amniocentesis involves using an ultrasound-guided,&#x000a0;hollow&#x000a0;needle through the maternal anterior abdominal wall into the amniotic cavity to draw out amniotic fluid for AFP&#x000a0;immunoassay.<xref ref-type="bibr" rid="article-17402.r16">[16]</xref>&#x000a0;AFP may also be measured by elution from blood spots collected on filter paper. Serum AFP is somewhat thermostable, and samples may be shipped at ambient temperatures after separation from red blood cells.<xref ref-type="bibr" rid="article-17402.r17">[17]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-17402.s3" sec-type="Procedures">
        <title>Procedures</title>
        <p>
<bold>Blood Sample Collection (Phlebotomy)</bold>
</p>
        <p>The process of blood sample collection typically involves the following steps:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Introduce yourself to the patient and confirm the pertinent identifiers, such as the patient's name and date of birth.</p>
          </list-item>
          <list-item>
            <p>Explain the procedure to the patient, warning the patient of possible discomfort from the needle&#x000a0;prick.</p>
          </list-item>
          <list-item>
            <p>Position the patient appropriately, exposing the upper arm.</p>
          </list-item>
          <list-item>
            <p>Follow hand washing protocols and adhere to basic universal precautions.</p>
          </list-item>
          <list-item>
            <p>Securely tie the tourniquet around the upper arm.</p>
          </list-item>
          <list-item>
            <p>Identify a prominent vein and sterilize the venipuncture site&#x000a0;with an alcohol swab.</p>
          </list-item>
          <list-item>
            <p>Insert the needle attached to a&#x000a0;vacutainer&#x000a0;into the vein.</p>
          </list-item>
          <list-item>
            <p>Once an adequate sample is obtained, remove the tourniquet and&#x000a0;withdraw&#x000a0;the needle.</p>
          </list-item>
          <list-item>
            <p>Apply the cotton ball to the needle site with pressure to stop bleeding.</p>
          </list-item>
          <list-item>
            <p>Label sample bottles appropriately.</p>
          </list-item>
          <list-item>
            <p>Send the sample for AFP assay.</p>
          </list-item>
        </list>
        <p>
<bold>Procedure for Amniocentesis (From 15 Weeks Gestation)</bold>
</p>
        <p>The subsequent steps outline the amniocentesis process:</p>
        <list list-type="bullet">
          <list-item>
            <p>Introduce yourself and confirm the patient's identity and gestational age of the pregnancy.</p>
          </list-item>
          <list-item>
            <p>Conduct pretest counseling, which typically includes genetic counseling.</p>
          </list-item>
          <list-item>
            <p>Obtain informed consent from the patient.</p>
          </list-item>
          <list-item>
            <p>Adhere to hand washing and universal precautions.</p>
          </list-item>
          <list-item>
            <p>Position the patient appropriately.</p>
          </list-item>
          <list-item>
            <p>Clean the exposed area of the abdomen.</p>
          </list-item>
          <list-item>
            <p>Use&#x000a0;a local anesthetic&#x000a0;if necessary.</p>
          </list-item>
          <list-item>
            <p>Carefully introduce the ultrasound-guided, hollow needle through the anterior abdominal wall into the amniotic cavity.</p>
          </list-item>
          <list-item>
            <p>Aspirate 15 to 20 mL of amniotic fluid.</p>
          </list-item>
          <list-item>
            <p>Send the sample&#x000a0;for AFP assay.</p>
          </list-item>
        </list>
        <p>
<bold>Procedure for&#x000a0;AFP Analysis</bold>
</p>
        <p>The procedure for&#x000a0;AFP analysis is as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Competitive radioimmunoassay has been widely used to quantify AFP.</p>
          </list-item>
          <list-item>
            <p>Currently, AFP is mainly measured by non-isotopic immunoassays.</p>
          </list-item>
          <list-item>
            <p>These immunoassay systems employ enzyme, fluorescent, or chemiluminescent labels.</p>
          </list-item>
          <list-item>
            <p>There are 2 types of&#x000a0;immunoassays&#x000a0;for measuring AFP: (1) competitive and (2) two-site solid-phase immunometric assays.</p>
          </list-item>
          <list-item>
            <p>In a typical radioisotopic competitive type, purified iodine-125-labeled AFP is mixed with the sample containing AFP to compete for a limited amount of AFP antibody.</p>
          </list-item>
          <list-item>
            <p>The 2-site immunometric assays use a solid phase, such as magnetic particles, plastic beads, or microtiter plates.</p>
          </list-item>
          <list-item>
            <p>The solid phase is coated with anti-AFP antibodies and incubated with patient specimens or standards.</p>
          </list-item>
          <list-item>
            <p>AFP in the sample reacts with the anti-AFP antibody and is immobilized in the solid phase.</p>
          </list-item>
          <list-item>
            <p>Unbound components of the specimen are removed by washing the solid phase.</p>
          </list-item>
          <list-item>
            <p>A second anti-AFP antibody labeled with an enzyme, radioactive, fluorescent, or chemiluminescent label is incubated with the solid phase and reacts with AFP bound at a second epitope site.</p>
          </list-item>
          <list-item>
            <p>Polyclonal and monoclonal antibodies have been used in tandem for each step.</p>
          </list-item>
          <list-item>
            <p>Washing the solid phase removes the unreacted label, and any additional reagent needed to generate a signal is added.</p>
          </list-item>
          <list-item>
            <p>The bound label can be measured directly in the case of a fluorescence or radioactive label.</p>
          </list-item>
          <list-item>
            <p>The solid phase must be incubated with substrate before the detection step for enzyme labels.</p>
          </list-item>
          <list-item>
            <p>A reagent must be added for chemiluminescence labels to generate the chemiluminescent signal.</p>
          </list-item>
          <list-item>
            <p>In all cases, the signal generated with the solid phase is directly proportional to the AFP concentration of the standard or unknown.</p>
          </list-item>
          <list-item>
            <p>AFP-L3% is measured using a microfluidics-based instrument that utilizes immunochemical and&#x000a0;electrophoretic techniques.</p>
          </list-item>
        </list>
        <p>
<bold>Quality Control Procedure</bold>
</p>
        <p>The insights into the quality control procedures implemented in laboratory settings include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Laboratory regulations require analyzing at least 2 levels of control materials every 24 hours for non-waived tests.</p>
          </list-item>
          <list-item>
            <p>Laboratories can more frequently assay quality control (QC) samples if necessary to ensure accurate results.</p>
          </list-item>
          <list-item>
            <p>QC&#x000a0;samples should be assayed after calibration or maintenance of an analyzer to verify the correct performance of the method.</p>
          </list-item>
          <list-item>
            <p>The laboratory can develop and implement an individualized quality control plan (IQCP) for specific analytes with different QC requirements.</p>
          </list-item>
          <list-item>
            <p>The IQCP involves performing a risk assessment of potential sources of error in all testing phases.</p>
          </list-item>
          <list-item>
            <p>After risk assessment, a QC plan is formulated to reduce the likelihood of errors.</p>
          </list-item>
          <list-item>
            <p>Westgard multi-rules are used to evaluate the&#x000a0;QC runs.</p>
          </list-item>
          <list-item>
            <p>If a run is declared out of control, the system, including the instrument, standards, controls, and other components, should be&#x000a0;investigated to determine the cause of the problem.</p>
          </list-item>
          <list-item>
            <p>Analysis should not be performed until the problem has been resolved.</p>
          </list-item>
        </list>
        <p>
<bold>Lab Safety</bold>
</p>
        <p>Safety precautions for handling laboratory materials include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Consider all specimens, control materials, and calibrator materials as potentially infectious.</p>
          </list-item>
          <list-item>
            <p>Exercise the normal precautions required for handling all laboratory reagents.</p>
          </list-item>
          <list-item>
            <p>Disposal of all waste material should be per local guidelines.</p>
          </list-item>
          <list-item>
            <p>Wear gloves, a lab coat, and safety glasses when handling human blood specimens.</p>
          </list-item>
          <list-item>
            <p>Dispose of all plastic tips, sample cups, and gloves that come into contact with blood in a biohazard waste container.</p>
          </list-item>
          <list-item>
            <p>Discard all disposable glassware into sharps waste containers.</p>
          </list-item>
          <list-item>
            <p>Protect all work surfaces with disposable absorbent benchtop paper&#x000a0;discarded into biohazard waste containers weekly or whenever blood contamination occurs.</p>
          </list-item>
          <list-item>
            <p>Wipe all work surfaces weekly.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17402.s4" sec-type="Indications">
        <title>Indications</title>
        <p>The following lists various situations or medical conditions in which an AFP&#x000a0;assay is performed:</p>
        <list list-type="bullet">
          <list-item>
            <p>Advanced maternal age</p>
          </list-item>
          <list-item>
            <p>Previous births with chromosomal or congenital disabilities, including neural tube defects</p>
          </list-item>
          <list-item>
            <p>Family history of chromosomal or congenital disabilities, such as Down syndrome and spina&#x000a0;bifida</p>
          </list-item>
          <list-item>
            <p>Screening for certain types of cancers, such as liver cancer, testicular cancer, and ovarian cancer.</p>
          </list-item>
          <list-item>
            <p>To evaluate the progress of anti-cancer treatment</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17402.s5" sec-type="Potential Diagnosis">
        <title>Potential Diagnosis</title>
        <p>
<bold>Maternal Serum AFP Levels Elevated</bold>
</p>
        <p>The following conditions are associated with elevated maternal serum AFP levels:</p>
        <list list-type="bullet">
          <list-item>
            <p>Neural tube defects such as spina&#x000a0;bifida and anencephaly</p>
          </list-item>
          <list-item>
            <p>Omphalocele</p>
          </list-item>
          <list-item>
            <p>Gastroschisis</p>
          </list-item>
          <list-item>
            <p>Sacrococcygeal teratoma</p>
          </list-item>
          <list-item>
            <p>Placental abnormalities</p>
          </list-item>
          <list-item>
            <p>Cystic hygroma</p>
          </list-item>
          <list-item>
            <p>Renal abnormalities such as polycystic kidney or absent kidney, urinary obstruction, and congenital nephrosis</p>
          </list-item>
          <list-item>
            <p>Osteogenesis imperfecta</p>
          </list-item>
          <list-item>
            <p>Threatened abortion</p>
          </list-item>
          <list-item>
            <p>Decreased maternal weight or intrauterine growth restriction</p>
          </list-item>
        </list>
        <p>
<bold>Maternal Serum AFP Low Levels</bold>
</p>
        <p>The following factors may contribute to low levels of maternal serum AFP:</p>
        <list list-type="bullet">
          <list-item>
            <p>Down syndrome</p>
          </list-item>
          <list-item>
            <p>Increased maternal weight</p>
          </list-item>
          <list-item>
            <p>Fetal demise</p>
          </list-item>
          <list-item>
            <p>Hydatidiform mole</p>
          </list-item>
          <list-item>
            <p>Trisomy 18, also known as Edwards&#x000a0;syndrome</p>
          </list-item>
          <list-item>
            <p>Incorrect gestational age (older than calculated)</p>
          </list-item>
        </list>
        <p>
<bold>Non-Pregnant Female or Male AFP Levels Elevated</bold>
</p>
        <p>The following conditions may lead to elevated AFP levels in non-pregnant females or males:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hepatocellular cancer</p>
          </list-item>
          <list-item>
            <p>Metastatic liver cancer</p>
          </list-item>
          <list-item>
            <p>Liver cirrhosis</p>
          </list-item>
          <list-item>
            <p>Hepatitis</p>
          </list-item>
          <list-item>
            <p>Germ cell tumors</p>
          </list-item>
          <list-item>
            <p>Yolk sac tumor</p>
          </list-item>
          <list-item>
            <p>Ataxia-telangiectasia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17402.s6" sec-type="Normal and Critical Findings">
        <title>Normal and Critical Findings</title>
        <p>Typical findings include:</p>
        <list list-type="bullet">
          <list-item>
            <p>AFP&#x000a0;levels in men and non-pregnant women vary by age and race but typically range from 0 to 40 ng/mL.</p>
          </list-item>
          <list-item>
            <p>Maternal AFP&#x000a0;levels increase&#x000a0;during pregnancy from about the 14th week of gestation until about 32 weeks.</p>
          </list-item>
          <list-item>
            <p>Between 15 and&#x000a0;20 weeks, AFP levels typically range between 10&#x000a0;and 150 ng/mL.</p>
          </list-item>
          <list-item>
            <p>Adult blood levels greater than 200 ng/mL in patients with liver cirrhosis strongly indicate hepatocellular carcinoma.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17402.s7" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>The following factors have&#x000a0;been implicated in false-positive AFP results:</p>
        <list list-type="bullet">
          <list-item>
            <p>A period of&#x000a0;2 weeks&#x000a0;after radiodiagnosis involving the use of radioactive tracers.</p>
          </list-item>
          <list-item>
            <p>Multiple gestations.</p>
          </list-item>
          <list-item>
            <p>Gestational diabetes.</p>
          </list-item>
          <list-item>
            <p>Cigarette smoking.</p>
          </list-item>
          <list-item>
            <p>Race (slightly higher levels in Black women and lower in women of Asian descent compared to Whites).</p>
          </list-item>
          <list-item>
            <p>Levels adjusted for weight.</p>
          </list-item>
          <list-item>
            <p>Amniotic fluid specimens contaminated with fetal blood may exhibit abnormally high AFP values, leading to misinterpretation of test results.</p>
          </list-item>
          <list-item>
            <p>Specimens from patients who have received preparations of mouse monoclonal antibodies may contain human anti-mouse antibodies, which may give falsely high results. Results must always be considered within the clinical&#x000a0;context and previous results, especially when serial results monitor a patient's response to treatment.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17402.s8" sec-type="Complications">
        <title>Complications</title>
        <p>Risks&#x000a0;associated with&#x000a0;phlebotomy include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Phlebitis</p>
          </list-item>
          <list-item>
            <p>Abnormal bruising and bleeding in patients with clotting disorders or those taking blood thinners</p>
          </list-item>
        </list>
        <p>Risks associated with amniocentesis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Miscarriage</p>
          </list-item>
          <list-item>
            <p>Preterm delivery</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17402.s9" sec-type="Patient Safety and Education">
        <title>Patient Safety and Education</title>
        <p>Phlebotomy for blood AFP assay requires little or no preparations, as this is safe when performed by qualified health professionals. However, patients need to be informed about the possible discomfort from the needle prick, which is generally bearable.&#x000a0;Patients&#x000a0;should be&#x000a0;inquired about their use of blood thinners&#x000a0;and should be given appropriate information regarding possible outcomes and implications of the test.<xref ref-type="bibr" rid="article-17402.r18">[18]</xref></p>
        <p>Explaining that this is a screening test is pertinent. Depending on the outcome, more tests may be ordered to establish a diagnosis.<xref ref-type="bibr" rid="article-17402.r19">[19]</xref> A negative test does not necessarily&#x000a0;indicate no risk, as very&#x000a0;low maternal blood AFP is associated with an increased incidence of Down syndrome. Hence, a low maternal blood AFP should be investigated.<xref ref-type="bibr" rid="article-17402.r20">[20]</xref></p>
        <p>Patients&#x000a0;undergoing amniocentesis must be counseled about the procedure and the associated risks.&#x000a0;The risk of obstetric mishap following amniocentesis exists; a miscarriage can happen in less than 1% of cases.&#x000a0;Some rare complications of amniocentesis include preterm labor, infection (amnionitis), iatrogenic trauma, or injury to the developing fetus or mother.<xref ref-type="bibr" rid="article-17402.r21">[21]</xref>&#x000a0;Following amniocentesis, patients may experience some&#x000a0;cramp-like discomfort in the first few hours but are usually allowed to go home after a short rest.<xref ref-type="bibr" rid="article-17402.r22">[22]</xref>&#x000a0;Oral paracetamol, such as acetaminophen, may be prescribed. Patients should report back to the hospital in case of vaginal bleeding, vaginal discharge, or increasing abdominal cramps.<xref ref-type="bibr" rid="article-17402.r23">[23]</xref></p>
      </sec>
      <sec id="article-17402.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Maternal blood AFP&#x000a0;levels often comprise triple, such as AFP, unconjugated estriol, and human chorionic gonadotropin, or quadruple, such as AFP,&#x000a0;estriol, human chorionic&#x000a0;gonadotropin, and inhibin A, screening tests for congenital disabilities.&#x000a0;Levels are typically interpreted for age, race, weight, and gestational age.&#x000a0;As the levels of these markers change with gestational age, the results are expressed as multiples-of-median.<xref ref-type="bibr" rid="article-17402.r24">[24]</xref> The elevated levels imply a significant risk&#x000a0;of having congenital disabilities; hence, further evaluation may be required to assess the level of risk.<xref ref-type="bibr" rid="article-17402.r25">[25]</xref> A substantial&#x000a0;number of&#x000a0;patients with elevated maternal AFP&#x000a0;do not develop congenital disabilities, but an increased risk of obstetric complications such as premature membrane rupture, placenta accreta, and increta may exist.<xref ref-type="bibr" rid="article-17402.r26">[26]</xref></p>
        <p>Low maternal AFP&#x000a0;levels may suggest a risk for Down syndrome.<xref ref-type="bibr" rid="article-17402.r27">[27]</xref> In non-pregnant women and men, elevated levels are&#x000a0;observed in cancers, especially liver cancer. Levels greater than 200 ng/mL in patients with cirrhosis suggest hepatocellular carcinoma. Elevated AFP levels can also be found in testicular and ovarian carcinoma. AFP is also useful for determining prognosis and monitoring therapy for hepatocellular carcinoma.<xref ref-type="bibr" rid="article-17402.r28">[28]</xref> The concentration of AFP is a prognostic indicator of survival. Elevated AFP concentrations (&#x0003e;10 &#x003bc;g/L) and serum bilirubin concentrations greater than 2 mg/dL are associated with a decreased survival time.<xref ref-type="bibr" rid="article-17402.r29">[29]</xref></p>
        <p>The lens culinary agglutinin-reactive fraction of fetoprotein (AFP-L3), a subtype of AFP produced by malignant hepatocytes, is considered specific to hepatocellular carcinoma. AFP-L3 is isolated using&#x000a0;immunoassay techniques and quantified using chemiluminescence on an automated platform.<xref ref-type="bibr" rid="article-17402.r30">[30]</xref> The proportion of AFP-L3 to total AFP can be used to diagnose early hepatocellular carcinoma. Early studies have reported that the diagnostic sensitivity of AFP-L3% for hepatocellular carcinoma ranged from 75% to 96.9%, with a specificity of 90% to 92%.<xref ref-type="bibr" rid="article-17402.r31">[31]</xref> The&#x000a0;high pre-treatment serum AFP-L3% levels indicated a poor prognosis for patients with hepatocellular carcinoma, and AFP-L3% may have a significant prognostic value for patients with hepatocellular carcinoma,&#x000a0;especially those with low AFP concentration.<xref ref-type="bibr" rid="article-17402.r32">[32]</xref></p>
        <p>A cutoff of 10% is used, and patients with chronic liver disease and an elevated AFP-L3% have a 7-fold increased risk of developing hepatocellular carcinoma within 21 months.<xref ref-type="bibr" rid="article-17402.r33">[33]</xref> The test is useful for early detection, particularly in the AFP range of 20 to 200 &#x003bc;g/L, as has been shown in patients with hepatitis C&#x02013;related cirrhosis. Although AFP-L3% is useful in detecting and prognosis,&#x000a0;the value is&#x000a0;typically used only when AFP concentrations are elevated.<xref ref-type="bibr" rid="article-17402.r34">[34]</xref></p>
        <p>The AFP concentration is a good indicator for monitoring therapy and assessing changes in the clinical status. Elevated AFP concentration after surgery may indicate incomplete removal of the tumor or the presence of metastasis.<xref ref-type="bibr" rid="article-17402.r35">[35]</xref> Falling or rising AFP concentration after therapy may reveal the success&#x000a0;or failure of the treatment regimen. A notable increase in AFP concentration in patients considered free of a metastatic tumor may indicate metastasis development.<xref ref-type="bibr" rid="article-17402.r5">[5]</xref></p>
        <p>Measuring AFP and human chorionic&#x000a0;gonadotropin concentration aids in classifying and staging germ cell tumors.<xref ref-type="bibr" rid="article-17402.r36">[36]</xref> Germ cell tumors may be predominantly&#x000a0;1 type of cell or a mixture of&#x000a0;various types, including seminoma, yolk sac, choriocarcinomatous elements (embryonal carcinoma), and teratoma. Serum concentrations of AFP are elevated in yolk sac tumors, whereas human chorionic&#x000a0;gonadotropin is elevated in choriocarcinoma. Both are elevated in embryonal carcinoma. AFP is not elevated in seminomas, whereas human chorionic&#x000a0;gonadotropin is elevated in 10% to 30% of patients with syncytiotrophoblastic tumor cells. Neither marker is elevated in teratoma.<xref ref-type="bibr" rid="article-17402.r37">[37]</xref></p>
        <p>One or both of the markers are elevated in about 90% of patients with non-seminomatous testicular tumors.<xref ref-type="bibr" rid="article-17402.r36">[36]</xref> Elevations are noted in less than 20% of patients with stage I, 50% to 80% with stage II, and 90% to 100% with stage III. These markers correlate with tumor volume and the prognosis of the disease.<xref ref-type="bibr" rid="article-17402.r38">[38]</xref>&#x000a0;The combined use of these markers is useful in monitoring patients with germ cell tumors: elevation of either marker indicates the recurrence of the disease or the development of metastasis. The effectiveness of chemotherapy can be assessed by calculating the decrease in the concentration of both markers using the half-lives&#x000a0;of AFP (5 days) and human chorionic&#x000a0;gonadotropin (12 to 20 hours).<xref ref-type="bibr" rid="article-17402.r39">[39]</xref></p>
      </sec>
      <sec id="article-17402.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17402&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17402">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17402/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17402">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17402.s12">
        <title>References</title>
        <ref id="article-17402.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pak</surname>
                <given-names>VN</given-names>
              </name>
            </person-group>
            <article-title>The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.</article-title>
            <source>Ther Deliv</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-46</page-range>
            <pub-id pub-id-type="pmid">29216804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yeh</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein.</article-title>
            <source>Hepatology</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>40</volume>
            <issue>4</issue>
            <fpage>847</fpage>
            <page-range>847-54</page-range>
            <pub-id pub-id-type="pmid">15382172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drugan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dvorin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Obrien</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <article-title>Alpha-fetoprotein.</article-title>
            <source>Curr Opin Obstet Gynecol</source>
            <year>1991</year>
            <month>Apr</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>230</fpage>
            <page-range>230-4</page-range>
            <pub-id pub-id-type="pmid">1717020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Favresse</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yolande</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gras</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of a Capillary Electrophoresis System for the Separation of Proteins.</article-title>
            <source>J Appl Lab Med</source>
            <year>2021</year>
            <month>Nov</month>
            <day>01</day>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>1611</fpage>
            <page-range>1611-1617</page-range>
            <pub-id pub-id-type="pmid">34086920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gish</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.</article-title>
            <source>Clin Liver Dis</source>
            <year>2015</year>
            <month>May</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>309</fpage>
            <page-range>309-23</page-range>
            <pub-id pub-id-type="pmid">25921665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharony</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dayan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kidron</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Manor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Berkovitz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Biron-Shental</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Maymon</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Is the ratio of maternal serum to amniotic fluid AFP superior to serum levels as a predictor of pregnancy complications?</article-title>
            <source>Arch Gynecol Obstet</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>293</volume>
            <issue>4</issue>
            <fpage>767</fpage>
            <page-range>767-70</page-range>
            <pub-id pub-id-type="pmid">26453361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicol</surname>
                <given-names>NH</given-names>
              </name>
            </person-group>
            <article-title>Atopic dermatitis: the (wet) wrap-up.</article-title>
            <source>Am J Nurs</source>
            <year>1987</year>
            <month>Dec</month>
            <volume>87</volume>
            <issue>12</issue>
            <fpage>1560</fpage>
            <page-range>1560-3</page-range>
            <pub-id pub-id-type="pmid">2891300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.</article-title>
            <source>Can J Gastroenterol Hepatol</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>9049252</fpage>
            <pub-id pub-id-type="pmid">29805966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yi</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bao</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.</article-title>
            <source>Clin Chim Acta</source>
            <year>2013</year>
            <month>Oct</month>
            <day>21</day>
            <volume>425</volume>
            <fpage>212</fpage>
            <page-range>212-20</page-range>
            <pub-id pub-id-type="pmid">23954771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Force</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chalikonda</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Halegoua-DeMarzio</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hann</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level.</article-title>
            <source>Viruses</source>
            <year>2022</year>
            <month>Apr</month>
            <day>08</day>
            <volume>14</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">35458505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>YD</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bang</surname>
                <given-names>HI</given-names>
              </name>
            </person-group>
            <article-title>Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>96</volume>
            <issue>11</issue>
            <fpage>e5811</fpage>
            <pub-id pub-id-type="pmid">28296720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giavarina</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Blood venous sample collection: Recommendations overview and a checklist to improve quality.</article-title>
            <source>Clin Biochem</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>50</volume>
            <issue>10-11</issue>
            <fpage>568</fpage>
            <page-range>568-573</page-range>
            <pub-id pub-id-type="pmid">28242283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crandall</surname>
                <given-names>BF</given-names>
              </name>
            </person-group>
            <article-title>Alpha-fetoprotein: a review.</article-title>
            <source>Crit Rev Clin Lab Sci</source>
            <year>1981</year>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>127</fpage>
            <page-range>127-85</page-range>
            <pub-id pub-id-type="pmid">6169490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaught</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Blood collection, shipment, processing, and storage.</article-title>
            <source>Cancer Epidemiol Biomarkers Prev</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>9</issue>
            <fpage>1582</fpage>
            <page-range>1582-4</page-range>
            <pub-id pub-id-type="pmid">16985016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gillio-Meina</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cepinskas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cecchini</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>Translational research in pediatrics II: blood collection, processing, shipping, and storage.</article-title>
            <source>Pediatrics</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>131</volume>
            <issue>4</issue>
            <fpage>754</fpage>
            <page-range>754-66</page-range>
            <pub-id pub-id-type="pmid">23509173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schell</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Drugan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brindley</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Zador</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <article-title>Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.</article-title>
            <source>J Reprod Med</source>
            <year>1990</year>
            <month>May</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>543</fpage>
            <page-range>543-6</page-range>
            <pub-id pub-id-type="pmid">1693689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaught</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Biological sample collection, processing, storage and information management.</article-title>
            <source>IARC Sci Publ</source>
            <year>2011</year>
            <issue>163</issue>
            <fpage>23</fpage>
            <page-range>23-42</page-range>
            <pub-id pub-id-type="pmid">22997855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lima-Oliveira</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Volanski</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Picheth</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Guidi</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Pre-analytical phase management: a review of the procedures from patient preparation to laboratory analysis.</article-title>
            <source>Scand J Clin Lab Invest</source>
            <year>2017</year>
            <month>May</month>
            <volume>77</volume>
            <issue>3</issue>
            <fpage>153</fpage>
            <page-range>153-163</page-range>
            <pub-id pub-id-type="pmid">28266238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ialongo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bernardini</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Phlebotomy, a bridge between laboratory and patient.</article-title>
            <source>Biochem Med (Zagreb)</source>
            <year>2016</year>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-33</page-range>
            <pub-id pub-id-type="pmid">26981016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wald</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cuckle</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>AFP and age screening for Down syndrome.</article-title>
            <source>Am J Med Genet</source>
            <year>1988</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>197</fpage>
            <page-range>197-209</page-range>
            <pub-id pub-id-type="pmid">2464930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uludag</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aydin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ibrahimova</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Madazli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Comparison of complications in second trimester amniocentesis performed with 20G, 21G and 22G needles.</article-title>
            <source>J Perinat Med</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>597</fpage>
            <page-range>597-600</page-range>
            <pub-id pub-id-type="pmid">20707629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cebesoy</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Balat</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Pehlivan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kutlar</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dikensoy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ugur</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Is pregnancy loss after amniocentesis related to the volume of amniotic fluid obtained?</article-title>
            <source>Arch Gynecol Obstet</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>279</volume>
            <issue>3</issue>
            <fpage>357</fpage>
            <page-range>357-60</page-range>
            <pub-id pub-id-type="pmid">18665378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tara</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lotfalizadeh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moeindarbari</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The effect of diagnostic amniocentesis and its complications on early spontaneous abortion.</article-title>
            <source>Electron Physician</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>2787</fpage>
            <page-range>2787-2792</page-range>
            <pub-id pub-id-type="pmid">27757190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wald</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Cuckle</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Brock</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Peto</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Polani</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Woodford</surname>
                <given-names>FP</given-names>
              </name>
            </person-group>
            <article-title>Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.</article-title>
            <source>Lancet</source>
            <year>1977</year>
            <month>Jun</month>
            <day>25</day>
            <volume>1</volume>
            <issue>8026</issue>
            <fpage>1323</fpage>
            <page-range>1323-32</page-range>
            <pub-id pub-id-type="pmid">69055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gagnon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>RD</given-names>
              </name>
              <collab>SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA GENETICS COMMITTEE</collab>
            </person-group>
            <article-title>Obstetrical complications associated with abnormal maternal serum markers analytes.</article-title>
            <source>J Obstet Gynaecol Can</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>10</issue>
            <fpage>918</fpage>
            <page-range>918-932</page-range>
            <pub-id pub-id-type="pmid">19038077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaur</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Srivastav</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Huria</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chavan</surname>
                <given-names>BS</given-names>
              </name>
            </person-group>
            <article-title>Maternal serum median levels of alpha-foetoprotein, human chorionic gonadotropin &#x00026; unconjugated estriol in second trimester in pregnant women from north-west India.</article-title>
            <source>Indian J Med Res</source>
            <year>2013</year>
            <volume>138</volume>
            <issue>1</issue>
            <fpage>83</fpage>
            <page-range>83-8</page-range>
            <pub-id pub-id-type="pmid">24056560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wan</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>The analysis of second-trimester triple screening for Down syndrome in Chinese normal singleton pregnancies.</article-title>
            <source>Scand J Clin Lab Invest</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>72</volume>
            <issue>8</issue>
            <fpage>642</fpage>
            <page-range>642-7</page-range>
            <pub-id pub-id-type="pmid">23057770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hadziyannis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sialevris</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Georgiou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Koskinas</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Analysis of serum &#x003b1;-fetoprotein-L3% and des-&#x003b3; carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total &#x003b1;-fetoprotein levels.</article-title>
            <source>Oncol Rep</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>835</fpage>
            <page-range>835-9</page-range>
            <pub-id pub-id-type="pmid">23174906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malov</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Malov</surname>
                <given-names>IV</given-names>
              </name>
              <name>
                <surname>Kuvshinov</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Marche</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Decaens</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Macek-Jilkova</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Yushchuk</surname>
                <given-names>ND</given-names>
              </name>
            </person-group>
            <article-title>Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.</article-title>
            <source>Sovrem Tekhnologii Med</source>
            <year>2021</year>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-33</page-range>
            <pub-id pub-id-type="pmid">34513063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YR</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>An</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yim</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Jeen</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Yeon</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Byun</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>YS</given-names>
              </name>
            </person-group>
            <article-title><italic>Lens culinaris</italic> agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma.</article-title>
            <source>World J Gastroenterol</source>
            <year>2021</year>
            <month>Jul</month>
            <day>28</day>
            <volume>27</volume>
            <issue>28</issue>
            <fpage>4687</fpage>
            <page-range>4687-4696</page-range>
            <pub-id pub-id-type="pmid">34366629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taketa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Win</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hlaing</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Wind</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar.</article-title>
            <source>Acta Med Okayama</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>56</volume>
            <issue>6</issue>
            <fpage>317</fpage>
            <page-range>317-20</page-range>
            <pub-id pub-id-type="pmid">12685861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khien</surname>
                <given-names>VV</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Chinh</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Bang</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Lac</surname>
                <given-names>BV</given-names>
              </name>
              <name>
                <surname>Hop</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>Tuan</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Don</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Taketa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Satomura</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma.</article-title>
            <source>Int J Biol Markers</source>
            <year>2001</year>
            <season>Apr-Jun</season>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>105</fpage>
            <page-range>105-11</page-range>
            <pub-id pub-id-type="pmid">11471892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bialecki</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Di Bisceglie</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of hepatocellular carcinoma.</article-title>
            <source>HPB (Oxford)</source>
            <year>2005</year>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-34</page-range>
            <pub-id pub-id-type="pmid">18333158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanif</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Susheela</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>IW</given-names>
              </name>
              <name>
                <surname>Luna-Cuadros</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>DT</given-names>
              </name>
            </person-group>
            <article-title>Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma.</article-title>
            <source>World J Gastroenterol</source>
            <year>2022</year>
            <month>Jan</month>
            <day>14</day>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>216</fpage>
            <page-range>216-229</page-range>
            <pub-id pub-id-type="pmid">35110946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Gan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.</article-title>
            <source>PLoS One</source>
            <year>2020</year>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>e0228857</fpage>
            <pub-id pub-id-type="pmid">32053643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dieckmann</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Simonsen-Richter</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kulejewski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anheuser</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zecha</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Isbarn</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pichlmeier</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.</article-title>
            <source>Biomed Res Int</source>
            <year>2019</year>
            <volume>2019</volume>
            <fpage>5030349</fpage>
            <pub-id pub-id-type="pmid">31275973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marshall</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Enzerra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rahnemai-Azar</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Ramaiya</surname>
                <given-names>NH</given-names>
              </name>
            </person-group>
            <article-title>Serum tumor markers and testicular germ cell tumors: a primer for radiologists.</article-title>
            <source>Abdom Radiol (NY)</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>1083</fpage>
            <page-range>1083-1090</page-range>
            <pub-id pub-id-type="pmid">30539249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murray</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Huddart</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>The present and future of serum diagnostic tests for testicular germ cell tumours.</article-title>
            <source>Nat Rev Urol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>12</issue>
            <fpage>715</fpage>
            <page-range>715-725</page-range>
            <pub-id pub-id-type="pmid">27754472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17402.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Song</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Xiong</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Xin</surname>
                <given-names>ZC</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>LQ</given-names>
              </name>
            </person-group>
            <article-title>The role of tumor size, ultrasonographic findings, and serum tumor markers in predicting the likelihood of malignant testicular histology.</article-title>
            <source>Asian J Androl</source>
            <year>2019</year>
            <season>Mar-Apr</season>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>196</fpage>
            <page-range>196-200</page-range>
            <pub-id pub-id-type="pmid">30648671</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
